Literature DB >> 29498967

Does Nonmetropolitan Residence Impact Timely Chlamydia Treatment in Massachusetts?

Jungwon Yoon, Heather R Elder1, Rebecca Hawrusik2, R Monina Klevens1, Kathleen A Roosevelt1, Katherine K Hsu.   

Abstract

A mean of 4.5 days until treatment was documented in a subset of reported laboratory-confirmed Massachusetts chlamydia cases selected for active case report form completion. Treatment delay was associated with longer test result turnaround time, and absence of symptoms or contact to sexually transmitted disease. Nonmetropolitan versus metropolitan residence did not appear to impact treatment time.

Entities:  

Mesh：

Year:  2018        PMID： 29498967     DOI： 10.1097/OLQ.0000000000000828

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  3 in total

1.  Chlamydia Treatment Practices and Time to Treatment in Massachusetts: Directly Observed Therapy Versus Pharmacy Prescriptions.

Authors:  Laura Platt; Heather Elder; Ingrid V Bassett; Lauren Molotnikov; Monina Klevens; Erin O'Connor; Dylan Leach; Kathleen Roosevelt; Katherine Hsu
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

2.  The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model.

Authors:  Minttu M Rönn; Ashleigh R Tuite; Nicolas A Menzies; Emory E Wolf; Thomas L Gift; Harrell W Chesson; Elizabeth Torrone; Andrés Berruti; Emanuele Mazzola; Kara Galer; Katherine Hsu; Joshua A Salomon
Journal:  Am J Epidemiol       Date:  2019-03-01       Impact factor: 4.897

3.  Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis.

Authors:  Minttu M Rönn; Nicolas A Menzies; Thomas L Gift; Harrell W Chesson; Tom A Trikalinos; Meghan Bellerose; Yelena Malyuta; Andrés Berruti; Charlotte A Gaydos; Katherine K Hsu; Joshua A Salomon
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.